Amphetamines and injection drug use are strongly associated with missed dosing and risky sexual behaviors in a large study of HIV-infected patients. Medscape Medical News
No Comments »
Filed under: General Health News
New data suggest treatment with an investigative buprenorphine implant significantly reduces opioid dependence. Medscape Medical News
No Comments »
Filed under: General Health News
Drs. William Kirby and Rady Rahban share the latest strategies for safe and effective tattoo removal in this expert interview. Medscape Dermatology
No Comments »
Filed under: General Health News
(MedPage Today) — Working out for just 15 minutes a day may add about three years to your life, researchers said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved vemurafenib (Zelboraf) for the treatment of metastatic and unresectable melanoma along with a companion genetic mutation test.
No Comments »
Filed under: General Health News
(MedPage Today) — Use of smokeless tobacco (or snuff) may increase the risk for heart failure, mainly of nonischemic origin and chiefly by increasing blood pressure and heart rate, a Swedish study found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — A new FDA user-fee program will require generic drugmakers to pay annual fees to speed up drug approvals and to increase inspections of foreign manufacturing plants.
No Comments »
Filed under: General Health News
(MedPage Today) — Seniors caught in the Medicare Part D coverage gap known as the “doughnut hole” are twice as likely to stop taking their medication, a new study found.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has approved vemurafenib (Zelboraf) for the treatment of metastatic and unresectable melanoma along with a companion genetic mutation test.
No Comments »
Filed under: Pharmacy News
Emergent BioSolutions Inc. today announced the initiation of a Phase 1b/2 study (16011) of TRU-016 in combination with rituximab and bendamustine for patients with relapsed indolent non-Hodgkin’s B-cell lymphomas, including follicular lymphoma, small lymphocytic lymphoma and marginal zone lymphoma.
No Comments »
Filed under: Pharmacy News
